12th International congress on Targeted Anticancer Therapies(TAT)

TAT congresses are leading annual meetings, run by the world’s top phase 1 investigators, on promising new drugs and molecular targets for cancer therapy in the early phases of clinical development:

Medium sized meetings offering excellent interaction and networking opportunities

International faculty including the world’s leading phase 1 investigators

High scientific standards

Plenary sessions only

Poster viewing sessions not coinciding with other program elements

Accredited learning for medical specialists in USA, Canada and Europe